Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that controlling shareholder Weigao Holding has expanded its position in the company’s H-shares through open-market purchases.
Between 13 May 2026 and 5 June 2026, Weigao Holding acquired a cumulative 14.95 million H-shares for approximately HK$50.90 million. The latest tranche—11.40 million shares bought from 15 May 2026 to 5 June 2026—represents 0.25% of both Weigao Group’s issued H-shares and total share capital.
Following the transactions, Weigao Holding’s ownership stands at 2.11 billion H-shares, equal to 46.76% of the company’s H-share float and 46.27% of total issued shares. The board highlighted that the purchases signal the shareholder’s confidence in Weigao Group’s long-term prospects.
The company reminded shareholders and potential investors to exercise caution when trading its securities.
Comments